Patents by Inventor Icilio Cavero

Icilio Cavero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-methyl-2-(3-pyridyl)-tetrahydrothio-pyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for treatment of coronary insufficiency
    Patent number: 5426117
    Abstract: Application of N-Methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide, in the form of a racemic mixture of the 1S,2S and 1R,2R isomers or in the form of the 1R,2R isomer, to the preparation of a medicinal product intended for the treatment of coronary insufficiency.
    Type: Grant
    Filed: February 4, 1993
    Date of Patent: June 20, 1995
    Assignee: Rhone-Poulenc Sante
    Inventors: Icilio Cavero, Serge Mondot
  • Pharmaceutical composition containing diltiazem and angiotensin-converting enzyme inhibitor
    Patent number: 4983598
    Abstract: Compositions of diltiazem and angiotensin-converting enzyme inhibitor useful for the treatment of hypertension, cardiac insufficiency and coronary insufficiency.
    Type: Grant
    Filed: May 18, 1988
    Date of Patent: January 8, 1991
    Assignee: Synthelabo
    Inventors: Icilio Cavero, Francois Elkik, Peter Hicks, Jean-Claude Muller
  • Pharmaceutical compositions
    Patent number: 4925837
    Abstract: Pharmaceutical compositions containing, by way of active substance, a combination of an alpha-blocker and a calcium antagonist. The composition is useful in treating cardiovascular disorders, especially hypertension.
    Type: Grant
    Filed: October 13, 1987
    Date of Patent: May 15, 1990
    Assignee: Synthelabo
    Inventors: Icilio Cavero, Jean-Louis Cazor, Peter Hicks, Salomon Langer
  • 1,2,3,4-tetrahydronaphthalene derivatives used as antiglaucoma agents
    Patent number: 4588747
    Abstract: 2-dipropylamino-5 or -7-formylamino-6-hydroxy-1,2,3-4-tetrahydronaphthalene and their pharmaceutically acceptable salts are useful as antiglaucoma agents.
    Type: Grant
    Filed: August 29, 1985
    Date of Patent: May 13, 1986
    Assignee: Synthelabo
    Inventors: Icilio Cavero, Salomon Z. Langer
  • Anti-ulcer agents
    Patent number: 4520030
    Abstract: 2-Dipropylamino-5 or -7-formylamino-6-hydroxy-1,2,3-4-tetrahydronaphthalene and their pharmaceutically acceptable salts are useful as anti-ulcer agents.
    Type: Grant
    Filed: December 12, 1983
    Date of Patent: May 28, 1985
    Assignee: Synthelabo
    Inventors: Icilio Cavero, Salomon Langer
  • Method of lowering intraocular pressure using phenylimino-imidazoles
    Patent number: 4515800
    Abstract: A method is provided of treating glaucoma in a patient which comprises administering, preferably as eye drops, an effective amount of the compound ##STR1## which is preferably in the form of its hydrochloride. The compound is administered preferably in the form of a sterile pharmacologically acceptable solution which contains from 0.1 to 5, and more preferably 0.1 to 2.0, percent by weight of said compound. The patient preferably obtains the anti-glaucoma agent in the form of a kit which comprises the sterile pharmacologically acceptable solution and an eyedropper for dispensing said sterile pharmacologically acceptable solution to the affected eyes of a patient suffering from glaucoma.
    Type: Grant
    Filed: August 3, 1983
    Date of Patent: May 7, 1985
    Inventors: Icilio Cavero, Salomon Z. Langer, Billie M. York, Jr.
  • Certain 2,5-disubstituted pyridine derivatives producing .beta.-adrenergic blocking action
    Patent number: 4406907
    Abstract: Pyridine derivatives of the formula: ##STR1## wherein R represents a group R.sub.1 O(CH.sub.2).sub.2 --, in which R.sub.1 is a (C.sub.3-6)cycloalkyl radical, a (C.sub.3-6)cycloalkyl-(C.sub.1-4)alkyl radical or allyl, and R' represents isopropyl or tert.-butyl, are new compounds useful in therapy in the treatment of cardiovascular maladies.
    Type: Grant
    Filed: March 24, 1982
    Date of Patent: September 27, 1983
    Assignee: Synthelabo
    Inventors: Philippe Manoury, Jean Binet, Icilio Cavero